Vitamin C Iv Therapy Dosage

IV Vitamin C Dosing Is More Complicated Than Most Practitioners Admit

Most clinics just grab a protocol sheet and run. They'll start someone at 10 grams, escalate weekly, and call it a day. The reality is that dosing intravenous vitamin C isn't one-size-fits-all. It depends on renal function, infusion rate tolerance, pH buffering, and what the patient actually came in for. Oncology protocols look completely different from wellness clinic protocols. I've seen people burn out on 25-gram infusions because nobody checked their G6PD status first. That's a hemolytic event waiting to happen. Let me walk through how I actually approach this, not the brochure version.

Understanding Vitamin C Iv Therapy Dosage

The doses used in clinical practice range from about 10 grams to 150 grams per infusion, though 150 grams is about as high as most people can tolerate without significant GI distress afterward. The pharmacokinetics are the main reason oral and IV dosing diverge so dramatically. Oral vitamin C has a saturable transporter system — the SVCT1 transporter in the gut and kidney basically caps blood levels around 200 micromolar. Go higher orally and you just get diarrhea. IV administration bypasses that completely. You can push blood concentrations into the millimolar range, which is where the pro-oxidant and potential anti-cancer mechanisms kick in. For general wellness and immune support, I typically see protocols in the 10 to 25 gram range given once or twice weekly. That's enough to raise plasma levels significantly above oral without pushing into the territory where side effects become common. For oncology applications, the literature starts getting interesting around 50 grams and above, with some protocols going to 100 grams per session. The de Groot and Peng studies at MD Anderson used 60 grams three times weekly as part of their Phase I trial framework.

Setting Up a Protocol from Scratch

Start with a baseline. Before you touch an IV line, you need a basic metabolic panel, a G6PD screening test, and a urine albumin-to-creatinine ratio. I can't stress the G6PD enough. A single missed case of G6PD deficiency and a 25-gram push can trigger acute hemolysis that lands someone in the ER. It takes ten minutes and fifty bucks to screen for it. Not doing so is negligent. For your first infusion in a new patient, I start at 10 grams diluted in 500 mL of normal saline. Run it over 60 to 90 minutes. Watch the patient for the first fifteen minutes like a hawk — that's when most acute reactions show up. Phlebitis at the site, a flushing sensation, a drop in blood pressure. If they tolerate it fine, you can increase by 5 grams per session until you hit either the desired therapeutic effect or the point where side effects become unacceptable. The most common side effect people complain about isn't serious but it's annoying. Osmotic diuresis. Vitamin C at high concentrations pulls water into the renal tubules. Patients will urinate aggressively for several hours after treatment. I tell people to hydrate well the day before and avoid scheduling back-to-back infusions on consecutive days. This usually cuts down on the dehydration complaints by about 80 percent.

Common Pitfalls and What Actually Works

Here's something most clinics don't tell you: the pH of the infusion solution matters more than people realize. Ascorbic acid is acidic. When you dissolve large amounts into saline, the pH can drop low enough to cause significant vein irritation. I buffer my solutions with sodium bicarbonate — roughly 1 to 2 grams per 10 grams of vitamin C. It makes the infusion considerably more comfortable and reduces phlebitis risk. Patients notice the difference immediately. They stop complaining about their arm burning halfway through. Another thing that trips people up is the assumption that more is always better. It's not. There's a ceiling effect on plasma concentration that varies between individuals. Some people clear vitamin C rapidly through the kidneys and never build up high levels no matter how much you infuse. Others have slower clearance and accumulate it. I've seen patients on 75-gram protocols who showed minimal improvement while another patient on 25 grams had dramatic symptom changes. Individual variability is real and predictable labs won't always tell you which camp someone falls into. You have to titrate clinically. The EDTA chelation crowd sometimes combines high-dose vitamin C with EDTA infusions. There's some mechanistic rationale for it — vitamin C can help mobilize certain metals while EDTA chelates them. But combining them increases the renal load significantly. I've seen two cases of acute kidney injury in patients running both protocols simultaneously without adequate hydration support. If you're doing this combo, make sure the patient is getting at least 2 liters of fluid on treatment days and monitor creatinine and BUN before and after each session.

What the Evidence Actually Supports

Let me be blunt about what this can and can't do. High-dose IV vitamin C is not a cure-all. The evidence for cancer treatment is mixed at best. Some small trials show improved quality of life and reduced chemotherapy side effects. A few show potential tumor stabilization. There is no robust randomized controlled trial demonstrating that IV vitamin C alone shrinks tumors or extends survival in humans. The preclinical data looks promising in cell lines and animal models, but translation to human oncology has been underwhelming so far. For sepsis and critical illness, the evidence is also thin. The CIVO trial in 2020 showed no mortality benefit from vitamin C infusion in septic patients. A few earlier studies were promising, but larger trials haven't replicated those findings. I won't recommend this for sepsis treatment outside of a research protocol. Where it does seem to have legitimate use is in supportive care — reducing oxidative stress, supporting collagen synthesis in wound healing, and potentially improving quality of life in chronic illness patients. The safety profile is favorable when you screen properly and dose responsibly. Adverse events are rare and usually mild: nausea, headache, infusion site discomfort, and the osmotic diuresis I mentioned.

A Problem I Ran Into That Isn't in the Literature

I had a patient on a 60-gram protocol for refractory post-viral fatigue. Every other week for three months, no issues. Then we switched her to a different compounding pharmacy and her 60-gram infusions suddenly became unbearable. Nausea, dizziness, tachycardia — symptoms she'd never experienced before at that dose. Same nominal dose, same patient. Turns out the new pharmacy was using a different grade of ascorbic acid with different excipient impurities. Once we went back to the original supplier, the problem disappeared completely. This is worth noting because most protocols don't specify pharmaceutical grade requirements, and the compounding landscape is inconsistent. Always verify what exactly is being infused, not just how much. General wellness and immune support: 10 to 25 grams once or twice weekly, infused over 60 to 90 minutes in 500 mL normal saline with optional bicarbonate buffering. Chronic inflammatory conditions: 25 to 50 grams two to three times weekly, infused over 90 to 120 minutes in 500 to 1000 mL saline.

Oncology supportive care: 50 to 100 grams two to three times weekly, infused over 2 to 3 hours in 1000 mL saline with bicarbonate. This requires oncology consultation and informed consent documentation. Renal function monitoring every cycle is mandatory. The upper limit for most practitioners should be around 100 grams unless you're working within a supervised research protocol. Going beyond that introduces diminishing returns and increasing risk without strong evidence to justify it. Kidney stones are a real concern at chronic high doses, especially in predisposed individuals. The oxalate pathway becomes relevant when you're pushing grams of vitamin C through the renal system daily. If you're considering this for yourself or a patient, the most important step isn't picking a dose. It's finding a provider who will actually run the screening tests, explain the risks honestly, and adjust based on individual response rather than following a template. The dosing table in any protocol sheet is a starting point, not a prescription.